PPARGC1A and Insulin resistance: Thus regularly active muscles due to exercises recommended in the STOP-NIDDM trial become a main protective or resilience factor against the development of insulin resistance and type 2 diabetes only in people with PGC1A GG genotype in contrast to those with PGC1A AA genotype shown sensitive in the same trial only to glucose-reducing treatment by acarbose (52).